Potential Drug Interaction Between Warfarin, COVID-19 Treatment Reported
A probable drug interaction was observed in 2 patients taking warfarin who were initiated on remdesivir and dexamethasone for the treatment of COVID-19.
Related Articles
FDA Clears Prescription Digital Therapeutic for Postpartum Depression
MamaLift Plus is intended as an adjunct to clinician-managed outpatient care to provide neurobehavioral interventions to patients 22 years of age and older with mild…
Anktiva Approved for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Nogapendekin alfa inbackicept-pmin is an interleukin-15 receptor agonist.
Entyvio for Subcutaneous Use Approved for Maintenance in Crohn Disease
The approval was based on data from the phase 3 VISIBLE 2 trial.
Tirzepatide Improves Sleep Apnea Symptoms in Obese Patients With OSA
The double-blind, phase 3 study included 2 groups of patients, those who were not on positive airway pressure therapy and those who were.
PowerHeal Bioelectric Bandage Available OTC for Wound Management
PowerHeal is indicated for superficial wounds such as minor cuts, scrapes, irritations, abrasions, and blisters and is available in a variety of sizes.
Meningococcal ABCWY Vaccine Candidate Under FDA Review
A regulatory decision is expected on February 14, 2025.
Entyvio for Subcutaneous Use Approved for Maintenance in Crohn Disease
The approval was based on data from the phase 3 VISIBLE 2 trial.
Tirzepatide Products Continue to Be in Short Supply
The shortage is expected to continue at least through the second quarter of 2024.
Sudan Ebola Virus Vaccine Candidate Gets Orphan Drug Status
SuVax is a subunit protein vaccine of recombinantly expressed Sudan ebolavirus glycoprotein.
US Medical Drug Shortages Reach Record High
A record high of 323 different meds were in short supply during the first quarter of 2024,